RESEARCH TRIANGLE PARK, N.C.--(EON: Enhanced Online News)--Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, today announced that John Goehrke has joined the company as CEO. In addition to the hiring of Mr. Goehrke, Centice has negotiated with current investors to provide up to $1.5 million in bridge financing to further the company's product manufacturing and drive additional sales and marketing programs.
“Centice delivers a superior product and I’m excited to lead the next stage of growth.”
In his new role as CEO, Goehrke will build on the company’s product innovation and client success and drive growth to cement its market leadership as Centice continues to emerge as a dominant force in chemical identification of narcotics, cutting agents, and controlled prescription drugs.
“I was drawn to Centice because it represents a combination of the best characteristics of all of my prior experiences – a team of winners, great technology vision, and a market that has a genuine need for the product,” noted Goehrke, CEO, Centice. “Centice delivers a superior product and I’m excited to lead the next stage of growth.”
Goehrke brings over 25 years of sales, marketing and general management experience to Centice. Most recently, he was CEO at Nextreme Thermal Solutions, which was sold to Laird Technologies in February 2013. Other operational roles include CEO of siXis Inc., pioneers of advanced Silicon Circuit Board (SiCB) technology, and COO of Luna Innovations, where he was part of the executive management team that successfully completed an Initial Public Offering. He earned his B.S. in Electrical Engineering from the University of Connecticut and M.B.A. from the University of Pittsburgh.
Prasant Potuluri, Centice’s co-founder who served as CEO and President since 2011, will continue his role as President and as a member of the Board of Directors. He will focus on leading international expansion and business development and driving the innovation of Centice's core technology.
Centice Corporation is a leader in delivering unique technology and systems for identification and verification of chemical substances. The MFL-3000, which uses Centice’s patented coded aperture Raman Spectroscopy technology, allows law enforcement agencies to quickly identify over 3,600 Controlled Prescription Drugs (CPD), street narcotics and cutting agent mixtures. The portable system provides field narcotic officers and drug interdiction agents with technology typically only available to crime labs. Operating worldwide through a network of distributors and support organizations the company sells to governments, non-governmental organizations (NGO), and local law enforcement departments. By leveraging expertise in applied Raman Spectroscopy and patented Coded Aperture design our engineers deliver on faster acquisition times, greater sensor reliability, and more sensitive spectra data acquisition. The company is headquartered in Morrisville, NC was founded in 2004 from technology created at Duke University.